Diabetes, a chronic condition affecting millions worldwide, necessitates early intervention to prevent severe complications. While accurately predicting diabetes onset or progression remains challenging due to complex and imbalanced datasets, recent advancements in machine learning offer potential solutions. Traditional prediction models, often limited by default parameters, have been superseded by more sophisticated approaches. Leveraging Bayesian optimization to fine-tune XGBoost, researchers can harness the power of complex data analysis to improve predictive accuracy. By identifying key factors influencing diabetes risk, personalized prevention strategies can be developed, ultimately enhancing patient outcomes. Successful implementation requires meticulous data management, stringent ethical considerations, and seamless integration into healthcare systems. This study focused on optimizing the hyperparameters of an XGBoost ensemble machine learning model using Bayesian optimization. Compared to grid search XGBoost (accuracy: 97.24%, F1-score: 95.72%, MCC: 81.02%), the XGBoost with Bayesian optimization achieved slightly improved performance (accuracy: 97.26%, F1-score: 95.72%, MCC:81.18%). Although the improvements observed in this study are modest, the optimized XGBoost model with Bayesian optimization represents a promising step towards revolutionizing diabetes prevention and treatment. This approach holds significant potential to improve outcomes for individuals at risk of developing diabetes.
In the present scenario, cancerous tumours are common in humans due to major changes in nearby environments. Skin cancer is a considerable disease detected among people. This cancer is the uncontrolled evolution of atypical skin cells. It occurs when DNA injury to skin cells, or a genetic defect, leads to an increase quickly and establishes malignant tumors. However, in rare instances, many types of skin cancer occur from DNA changes tempted by infrared light affecting skin cells. This disease is a worldwide health problem, so an accurate and appropriate diagnosis is needed for efficient treatment. Current developments in medical technology, like smart recognition and analysis utilizing machine learning (ML) and deep learning (DL) techniques, have transformed the analysis and treatment of these conditions. These approaches will be highly effective for the recognition of skin cancer utilizing biomedical imaging. This study develops a Multi-scale Feature Fusion of Deep Convolutional Neural Networks on Cancerous Tumor Detection and Classification (MFFDCNN-CTDC) model. The main aim of the MFFDCNN-CTDC model is to detect and classify cancerous tumours using biomedical imaging. To eliminate unwanted noise, the MFFDCNN-CTDC method initially utilizes a sobel filter (SF) for the image preprocessing stage. For the segmentation process, Unet3+ is employed, providing precise localization of tumour regions. Next, the MFFDCNN-CTDC model incorporates multi-scale feature fusion by combining ResNet50 and EfficientNet architectures, capitalizing on their complementary strengths in feature extraction from varying depths and scales of the input images. The convolutional autoencoder (CAE) model is utilized for the classification method. Finally, the parameter tuning process is performed through a hybrid fireworks whale optimization algorithm (FWWOA) to enhance the classification performance of the CAE model. A wide range of experiments is performed to authorize the performance of the MFFDCNN-CTDC approach. The experimental validation of the MFFDCNN-CTDC approach exhibited a superior accuracy value of 98.78% and 99.02% over existing techniques under ISIC 2017 and HAM10000 datasets.
skin cancer detectionskin lesion classificationmulti-scale feature fusionconvolutional neural networks
In recent times, the global rise in the prevalence rate of amyotrophic lateral sclerosis (ALS) has profoundly affected the welfare of several people in the world. ALS is a lethal neurodegenerative disease (NDD) that damages the nerve cells in the brain and spinal cord. Moreover, it removes the person’s capability of controlling muscle movements in the body. It is necessary to detect the disease earlier, to reduce the disease severity, and to enhance the life expectancy of the patients. Traditionally, ALS screening is handled by qualified physicians through blood tests, which is an expensive, painful, and time-consuming process. To resolve this limitation, several researchers focused on the ALS classification. Conversely, it have a few drawbacks, such as lack of accuracy and speed, overfitting of data, and noise handling tasks. For enhancing the classification of ALS, the proposed approach employs progressive entropy weighted-based focal loss (PEWFL)-XGBoost through the Kaggle ALS dataset. The XGBoost is used for the ability to manage missing data and speed. Nevertheless, it has certain limitations such as overfitting of data, hyperparameter tuning, and handling of smaller datasets. To resolve this, PEWFL is added to the XGBoost system to improve the classification performance. Correspondingly, the efficiency of the respective system is calculated using performance metrics to evaluate the performance of the research. Moreover, internal comparison with classical algorithms such as XGBoost, K-nearest neighbor, and random forest discloses the efficacy of the respective model. The proposed system is envisioned to contribute to molecular genetics and neuroscience research and assist neurologists in enhancing the diagnosis of ALS.
Down syndrome (DS) is a genetic condition characterized by distinct facial features and developmental challenges, making early and accurate detection crucial for timely intervention and support. Traditional diagnostic methods often require specialized expertise, which can be resource intensive and inaccessible in many settings. In this study, we propose a novel artificial intelligence (AI)-driven approach to detecting DS using facial images, leveraging advancements in deep learning and machine learning for accurate and scalable diagnostics. A dataset of 168 facial images was curated from publicly accessible platforms, comprising 95 images of individuals without DS and 73 with the condition. The model was implemented using TensorFlow/PyTorch and employs RegNet X and Shifted Window Transformer (SWIN Transformer) for feature extraction, capturing both local and global facial features. To enhance feature representation, an attention-based fusion mechanism was applied, prioritizing the most discriminative patterns while filtering redundant information. For classification, an Extremely Randomized Tree (ExtraTrees) model was employed, known for its ability to efficiently handle high-dimensional data with strong generalization capabilities. The model was fine-tuned using Bayesian Optimization and Hyperband (BOHB), which optimized hyperparameters by balancing exploration and exploitation, thereby improving predictive performance. The final classification achieved a 99.2% accuracy with an area under the curve (AUC) of 1.00, demonstrating exceptional reliability in distinguishing DS from normal cases. By combining advanced feature extraction, fusion, and classification techniques, this study highlights the potential of AI to revolutionize DS diagnostics, offering a non-invasive, efficient, and scalable solution for early detection.
Down syndromeface classificationearly diagnosismodel interpretability
Across the globe, chronic obstructive pulmonary disease (COPD) continues to be a critical healthcare burden due to its progressive and undetected decline in pulmonary function. In recent times, convolutional neural networks (CNNs) and vision transformers (ViTs) have been widely applied to lung sounds (LS) analysis, leading to the development of improved non-invasive, accessible, and scalable COPD screening methods. However, the shortcomings of CNNs and ViTs architectures restrict the COPD classifier’s discriminative power in distinguishing normal and COPD samples. In this study, a unique and interpretable COPD classification is proposed. This study introduces a hybrid feature extraction strategy integrating CNNs and ViTs architecture to capture the crucial COPD patterns from the LS’s Mel-spectrogram representation. The proposed CNNs-ViTs architecture addresses the limitations of standalone CNNs or ViTs architectures by capturing fine-grained acoustic features and long-range temporal dependencies while efficiently modeling non-linear relationships. A novel feature fusion is used to combine the heterogeneous features into a unified and highly discriminative feature representation space. A tailored hyperparameter optimization strategy is developed to fine-tune the Kolmogorov-Arnold Networks (KANs) for classifying the features into normal and COPD classes. By incorporating internal (552 Healthy and 1324 COPD LS recordings) and external (35 Healthy and 77 COPD LS recordings) datasets, the authors evaluate the model’s performance. The model achieves a generalization accuracy of 97.62% and specificity of 96.51% on the external dataset. Through Shapley Additive Explanations (SHAP) overlays, the model’s interpretability is enhanced. The experimental findings highlight the effectiveness of the proposed COPD classification architecture in the domain of biomedical acoustic signal processing. Operating with minimal reliance on specialized diagnostic infrastructure renders the proposed model ideal for primary care and resource-limited environments.
Hematological biomarkers have emerged as powerful tools in diagnosing Acute Heart Failure (AHF). This study introduces a novel diagnostic framework that integrates Explainable Artificial Intelligence (XAI) with Morris Sensitivity Analysis (MSA) to enhance both the interpretability and performance of machine learning models in AHF detection. A dataset consisting of 425 AHF patients and 430 controls was analyzed using eight machine learning models, including XGBoost, Histogram-based Gradient Boosting (histGB), Explainable Boosting Machine (EBM), and Random Forest. Model performance was evaluated through metrics such as AUC, accuracy, precision, recall, and Brier score. Hyperparameters were optimized via Bayesian optimization. Feature importance was assessed using MSA to identify variables with the highest predictive influence. The histGB model achieved the highest performance with an AUC of 87.93%. Both MSA and EBM consistently identified PDW, RDW-CV, NEU, NEU/LY ratio, age, and WBC as top predictive features across multiple models. These hematological markers demonstrated strong potential for early diagnosis and risk stratification in AHF patients. This study presents a clinically relevant, interpretable, and cost-effective diagnostic strategy that combines XAI with MSA for AHF prediction. The framework enhances clinical trust and provides a pathway toward personalized treatment by identifying accessible hematological biomarkers. The integration of explainability into AI models improves their transparency and applicability in real-world clinical settings.